- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 124.83M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.97M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $16.95M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.4M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.05M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.42M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.07M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $15.37M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $17.5M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $17M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $18.97M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 121.22M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $51K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.32M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $4.14M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $4.95M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.26M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.07M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.22M |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |